Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Theralase Technologies Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $156.35M | $156.35M - $156.35M | -$156.35M | $0.13 | 1 |
| Dec 2029 | $115.46M | $115.46M - $115.46M | -$115.46M | $0.09 | 1 |
| Dec 2028 | $74.69M | $74.69M - $74.69M | -$74.69M | $0.05 | 1 |
| Dec 2027 | $33.89M | $33.89M - $33.89M | -$33.89M | $0.02 | 1 |
| Dec 2026 | $802.0K | $802.0K - $802.0K | -$802.0K | -$0.01 | 1 |
| Dec 2025 | $880.0K | $880.0K - $880.0K | -$880.0K | -$0.01 | 1 |
| Dec 2024 | $1.03M | $1.03M - $1.03M | -$1.03M | -$0.013 | 1 |
| Dec 2023 | $1.07M | $1.07M - $1.07M | -$1.07M | -$0.01 | 1 |
| Dec 2022 | $1.14M | $1.14M - $1.14M | -$1.14M | -$0.03 | 1 |
| Dec 2021 | $867.0K | $867.0K - $867.0K | -$867.0K | -$0.02 | 1 |
| Dec 2020 | $929.0K | $929.0K - $929.0K | -$929.0K | -$0.03 | 1 |
| Dec 2019 | $815.0K | $815.0K - $815.0K | -$815.0K | -$0.04 | 1 |